|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2500113983 |
|
最近更新日期: Date of Last Refreshed on: |
2025-12-05 08:25:44 |
|
注册时间: Date of Registration: |
2025-12-05 00:00:00 |
|
注册号状态: |
补注册 |
|
Registration Status: |
Retrospective registration |
|
注册题目: |
面向医疗场景的高精度永磁定位技术研究 |
|
Public title: |
Research on High-Precision Permanent Magnetic Tracking Technology for Medical Applications |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
面向医疗场景的高精度永磁定位技术研究 |
|
Scientific title: |
Research on High-Precision Permanent Magnetic Tracking Technology for Medical Applications |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
秦岩丁 |
研究负责人: |
秦岩丁 |
|
Applicant: |
Yanding Qin |
Study leader: |
Yanding Qin |
|
申请注册联系人电话: Applicant telephone: |
+86 22 8535 8853 |
研究负责人电话:
Study leader's |
+86 22 8535 8853 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
qinyd@nankai.edu.cn |
研究负责人电子邮件: Study leader's E-mail: |
qinyd@nankai.edu.cn |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
天津市津南区海河教育园区同砚路38号 |
研究负责人通讯地址: |
天津市津南区海河教育园区同砚路38号 |
|
Applicant address: |
No. 38, Tongyan Road, Haihe Education Park, Jinnan District, Tianjin City |
Study leader's address: |
No. 38, Tongyan Road, Haihe Education Park, Jinnan District, Tianjin City |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
南开大学 |
||
|
Applicant's institution: |
Nankai University |
||
|
研究负责人所在单位: |
南开大学 |
||
|
Affiliation of the Leader: |
Nankai University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
NKUIRB2025183 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
南开大学生物医学伦理委员会 |
||
|
Name of the ethic committee: |
Nankai University Institutional Review Board |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2025-11-03 00:00:00 | ||
|
伦理委员会联系人: |
张博 |
||
|
Contact Name of the ethic committee: |
Zhang Bo |
||
|
伦理委员会联系地址: |
天津市津南区海河教育园区同砚路38号 |
||
|
Contact Address of the ethic committee: |
No. 38, Tongyan Road, Haihe Education Park, Jinnan District, Tianjin City |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 22 8535 8853 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
leon7simon@nankai.edu.cn |
|
研究实施负责(组长)单位: |
南开大学 |
||||||||||||||||||||||
|
Primary sponsor: |
Nankai University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
天津市津南区海河教育园区同砚路38号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 38, Tongyan Road, Haihe Education Park, Jinnan District, Tianjin City |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
国家重点研发计划课题 |
||||||||||||||||||||||
|
Source(s) of funding: |
A project under the National Key Research and Development Program |
||||||||||||||||||||||
|
研究疾病: |
无 |
||||||||||||||||||||||
|
Target disease: |
None |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
单臂 |
||||||||||||||||||||||
|
Study design: |
Single arm |
||||||||||||||||||||||
|
研究目的: |
本项目旨在研究高精度永磁定位技术在医疗场景下的应用,为医学导航提供新思路,加速永磁定位技术在医疗领域的应用。 |
||||||||||||||||||||||
|
Objectives of Study: |
This project aims to study the application of high-precision permanent magnet positioning technology in medical scenarios, provide new ideas for medical navigation, and accelerate the application of permanent magnet positioning technology in the medical field. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1.年龄:18 岁及以上(成年人)。 2.生理功能正常、心理状态良好(经南开大学校医院医师评估通过)。 3.情绪稳定,能理解和配合实验全过程并签署知情同意书。 4.愿意接受体外短时间固定靶标并同意采集自身生理活动数据。 |
||||||||||||||||||||||
|
Inclusion criteria |
1.Age: 18 years old and above (adult). 2. Normal physiological functions and good mental state (evaluated and approved by the physicians of Nankai University Hospital). 3. Emotionally stable, able to understand and cooperate with the entire experimental process and sign the informed consent form. 4. Be willing to accept short-term fixed targets in vitro and agree to collect one's own physiological activity data. |
||||||||||||||||||||||
|
排除标准: |
1.存在生理功能缺陷或明显疾病等(经医师评估认定不能参与者)。 2.无法在实验过程中保持相对情绪稳定或有严重精神/认知障碍影响配合。 3.有开放性皮肤病变或对绑带/靶标材料可能有严重过敏史。 4.妊娠期妇女 5.其他经研究者或医师评估认为不适合参加的情况。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Those with physiological functional defects or obvious diseases (as determined by a physician to be unable to participate). 2. Unable to maintain relative emotional stability during the experiment or having severe mental/cognitive impairments that affect cooperation. 3. There may be open skin lesions or a history of severe allergy to the binding straps/target materials. 4. Pregnant women 5. Other circumstances where participation is deemed unsuitable by researchers or physicians. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2025-11-04 00:00:00至 To 2028-11-04 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2025-11-04 00:00:00 至 To 2028-11-04 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
无 |
|
Blinding: |
None |
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
研究结束后,通过ResMan(www.medresman.org.cn)方式共享 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
After the end of the study, it was shared by ResMan (www.medresman.org.cn). |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
EDC |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
EDC |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |